Is a triple-therapy inhaler the next move in asthma?

First trials find modest reductions in exacerbations

Adults with uncontrolled asthma may benefit from a three-in-one inhaler that adds a long-acting muscarinic receptor antagonist to LABA-ICS, researchers say.